SCOPUS 정보 검색 플랫폼

Trends in Pharmacological Sciences

Volumn 34, Issue 12, 2013, Pages 645-647

Raw data from clinical trials: Within reach?

(3) Doshi, Peter a Goodman, Steven N b Ioannidis, John P A b

a Stanford University School of Medicine ^*

b STANFORD UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; PIRFENIDONE;

ACCESS TO INFORMATION; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONFIDENTIALITY; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG INFORMATION; FIBROSING ALVEOLITIS; FREEDOM OF INFORMATION ACT; GOVERNMENT REGULATION; INFORMATION DISSEMINATION; PRIORITY JOURNAL; PRIVACY; PUBLICATION; RHEUMATOID ARTHRITIS;

EID: 84889076911 PISSN: 01656147 EISSN: 18733735 Source Type: Journal
DOI: 10.1016/j.tips.2013.10.006 Document Type: Note

Times cited : (44)

References (10)

1
- 84880893300
- Access to patient-level data from GlaxoSmithKline clinical trials
- P. Nisen, and F. Rockhold Access to patient-level data from GlaxoSmithKline clinical trials N. Engl. J. Med. 369 2013 475 478
- (2013) N. Engl. J. Med. , vol.369 , pp. 475-478
- Nisen, P.¹ Rockhold, F.²

2
- 84874893971
- The first 2 years of the European Medicines Agency's policy on access to documents: Secret no longer
- P. Doshi, and T. Jefferson The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer JAMA Intern. Med. 173 2013 380 382
- (2013) JAMA Intern. Med. , vol.173 , pp. 380-382
- Doshi, P.¹ Jefferson, T.²

3
- 17344366114
- Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: A meta-analysis of randomized individual patient data
- J.P. Ioannidis Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data J. Infect. Dis. 178 1998 349 359
- (1998) J. Infect. Dis. , vol.178 , pp. 349-359
- Ioannidis, J.P.¹

4
- 84880857852
- Participant-level data and the new frontier in trial transparency
- D.A. Zarin Participant-level data and the new frontier in trial transparency N. Engl. J. Med. 369 2013 468 469
- (2013) N. Engl. J. Med. , vol.369 , pp. 468-469
- Zarin, D.A.¹

5
- 84888026156
- Transparency interrupted: The curtailment of the European Medicines Agency's policy on access to documents
- 10.1001/jamainternmed.2013.9989
- P. Doshi Transparency interrupted: the curtailment of the European Medicines Agency's policy on access to documents JAMA Intern. Med. 2013 10.1001/jamainternmed.2013.9989
- (2013) JAMA Intern. Med.
- Doshi, P.¹

6
- 84876517223
- Transforming epidemiology for 21st century medicine and public health
- M.J. Khoury Transforming epidemiology for 21st century medicine and public health Cancer Epidemiol. Biomarkers Prev. 22 2013 508 516
- (2013) Cancer Epidemiol. Biomarkers Prev. , vol.22 , pp. 508-516
- Khoury, M.J.¹

7
- 80052526021
- Public availability of published research data in high-impact journals
- A.A. Alsheikh-Ali Public availability of published research data in high-impact journals PLoS ONE 6 2011 e24357
- (2011) PLoS ONE , vol.6 , pp. 24357
- Alsheikh-Ali, A.A.¹

8
- 82755192534
- Improving validation practices in 'omics' research
- J.P.A. Ioannidis, and M.J. Khoury Improving validation practices in 'omics' research Science 334 2011 1230 1232
- (2011) Science , vol.334 , pp. 1230-1232
- Ioannidis, J.P.A.¹ Khoury, M.J.²

9
- 82755174123
- Reproducible research in computational science
- R.D. Peng Reproducible research in computational science Science 334 2011 1226 1227
- (2011) Science , vol.334 , pp. 1226-1227
- Peng, R.D.¹

10
- 70349464471
- Empirical study of data sharing by authors publishing in PLoS journals
- C.J. Savage, and A.J. Vickers Empirical study of data sharing by authors publishing in PLoS journals PLoS ONE 4 2009 e7078
- (2009) PLoS ONE , vol.4 , pp. 7078
- Savage, C.J.¹ Vickers, A.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.